p53 Transcriptional Activation Mediated by Coactivators TAF II 40 and TAF II 60
- 6 January 1995
- journal article
- other
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 267 (5194) , 100-104
- https://doi.org/10.1126/science.7809597
Abstract
The tumor suppressor protein p53 is a transcriptional regulator that enhances the expression of proteins that control cellular proliferation. The multisubunit transcription factor IID (TFIID) is thought to be a primary target for site-specific activators of transcription. Here, a direct interaction between the activation domain of p53 and two subunits of the TFIID complex, TAFII40 and TAFII60, is reported. A double point mutation in the activation domain of p53 impaired the ability of this domain to activate transcription and, simultaneously, its ability to interact with both TAFII40 and TAFII60. Furthermore, a partial TFIID complex containing Drosophila TATA binding protein (dTBP), human TAFII250, dTAFII60, and dTAFII40 supported activation by a Gal4-p53 fusion protein in vitro, whereas TBP or a subcomplex lacking TAFII40 and TAFII60 did not. Together, these results suggest that TAFII40 and TAFII60 are important targets for transmitting activation signals between p53 and the initiation complex.Keywords
This publication has 36 references indexed in Scilit:
- Drosophila TFIIA directs cooperative DNA binding with TBP and mediates transcriptional activation.Genes & Development, 1994
- Assembly of recombinant TFIID reveals differential coactivator requirements for distinct transcriptional activatorsCell, 1994
- Crystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic MutationsScience, 1994
- Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein.Genes & Development, 1994
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993
- Cooperative DNA binding of p53 with TFIID (TBP): a possible mechanism for transcriptional activation.Genes & Development, 1993
- Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53Nature, 1993
- Site-specific binding of wild-type p53 to cellular DNA is inhibited by SV40 T antigen and mutant p53.Genes & Development, 1992
- The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivationCell, 1992
- Mechanism of transcriptional activation by Sp1: Evidence for coactivatorsCell, 1990